POAS peer analysis
Phaos Technology (POAS) against its competitors: price, today's move, 1-year return and market value side by side.
POAS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CV CapsoVision | $6.27 | -1.57% | 15.15% | $313.79M |
| CVRX CVRx | $0.70 | 0.70% | -92.88% | $19.95M |
| HYPR Hyperfine | $0.71 | 4.42% | -35.34% | $75.54M |
| MIAX Miami International | $36.10 | -2.06% | -27.04% | $3.61B |
| MXCT MaxCyte | $1.18 | 7.27% | -23.87% | $121.78M |
| NSRX Nasus Pharma | $2.91 | -2.51% | -63.12% | $25.06M |
| PFSA Profusa | $0.45 | -17.85% | -99.97% | $2.11M |
| SI Shoulder Innovations | $21.05 | -3.97% | 85.30% | $440.41M |
| TCMD Tactile Systems | $26.84 | -1.09% | 6.91% | $601.14M |
| POAS Phaos Technology | $2.66 | 195.33% | – | $2.43M |
- POAS's peers: CV (CapsoVision), CVRX (CVRx), HYPR (Hyperfine), MIAX (Miami International), MXCT (MaxCyte), NSRX (Nasus Pharma), PFSA (Profusa), SI (Shoulder Innovations).
Updated 2026-11-13 05:48 UTC